Target intelligence / Profile preview

Host immune receptors recognizing SARS-CoV-2 spike protein

Molecular classification
Receptor, Pattern recognition receptor, Toll-like receptor, C-type lectin receptor
01

Overview

Host immune receptors recognizing the SARS-CoV-2 spike protein are a diverse group of pattern recognition receptors (PRRs) and cell-surface molecules that identify the viral spike (S) glycoprotein to initiate or modulate the host immune response. This group includes Toll-like receptors, notably TLR4 and TLR2, which recognize the S1 and S2 subunits of the spike protein to trigger the NF-κB signaling pathway and the subsequent release of pro-inflammatory cytokines such as IL-6 and TNF-α (Zhao et al., 2021; Khan et al., 2021). Additionally, C-type lectin receptors (CLRs) such as DC-SIGN (CD209), L-SIGN (CLEC4M), and MGL (CLEC10A) bind to the glycans on the spike protein, potentially acting as alternative attachment factors that facilitate viral entry or promote the infection of susceptible cells (Amraei et al., 2021; Lu et al., 2021). While these interactions are essential for the innate detection of the pathogen, their dysregulation is a major contributor to the hyper-inflammatory state or "cytokine storm" observed in severe COVID-19 cases (Nature Reviews Immunology, 2021). Therapeutic strategies targeting these receptors, such as the TLR4 antagonist Eritoran or various experimental glycomimetics, aim to dampen pathological inflammation and block non-ACE2 mediated viral pathways. These interventions must be carefully balanced to reduce tissue damage without compromising the host's ability to clear the viral infection.

Other names
Pattern recognition receptors (PRRs)SARS-CoV-2 spike-binding immune receptorsToll-like receptor 4 (TLR4)Toll-like receptor 2 (TLR2)Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN/CD209)Liver/lymph node-specific ICAM-3-grabbing non-integrin (L-SIGN/CLEC4M)Macrophage galactose-type lectin (MGL/CLEC10A)Sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169)
02

Mechanism of action

Competitive antagonism of pattern recognition receptors to block viral protein-induced inflammatory signaling and inhibit lectin-mediated viral attachment.

03

Biological functions

Immune responseSignal transductionCytokine productionViral recognitionInflammation
04

Disease associations

InfectionInflammationCOVID-19
05

Safety considerations

ImmunosuppressionIncreased risk of secondary infectionsImpaired viral clearanceOff-target inflammatory modulation
06

Interacting drugs

Eritoran

3 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)C-reactive protein (CRP)FerritinSoluble CD14 (sCD14)

Beyond the preview

Go deeper on Host immune receptors recognizing SARS-CoV-2 spike protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host immune receptors recognizing SARS-CoV-2 spike protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call